| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/29/2004 | US20040082519 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 04/29/2004 | US20040082502 Method for treating wounds to promote healing |
| 04/29/2004 | US20040082022 Solutions for use as plasma expanders and substitutes |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081707 Tetraglycol as a solvent for molecular iodine in the preparation of a topical counter-irritant against skin burns |
| 04/29/2004 | US20040081701 Mixing hydrolyzed cellulose with a water of hydration of 30-90% with at least one relatively water-insoluble pharmaceutically active agent |
| 04/29/2004 | US20040081700 Partial doses of the active ingredient can accurately and reliably dispensed from the bulk formulations of proton pump inhibitor microgranules suspended in sufficiently viscous liquid |
| 04/29/2004 | US20040081699 Quickly disintegrate in aqueous media |
| 04/29/2004 | US20040081697 Single daily dose of insulin sensitizer and another antidiabetic agent, such as an alpha glucosidase inhibitor, a biguanide or an insulin secretagogue |
| 04/29/2004 | US20040081696 Irradiation directly transfers the energy required to evaporate the solvent to the drug coated particle |
| 04/29/2004 | US20040081695 Immediate release tablet can be made from a mixture comprising at least 60 weight % active ingredient(s) and a powdered wax having a melting point of greater than about 90 degrees C. |
| 04/29/2004 | US20040081694 Melt-extruded orally administrable opioid formulations |
| 04/29/2004 | US20040081693 Capable of releasing the drug at a constant rate following zero order kinetics for 24 hours or more |
| 04/29/2004 | US20040081692 Predictive model for designing modified release products |
| 04/29/2004 | US20040081691 Neutral core coated with a layer containing the plant substance, coated with an outer layer intended to mask the taste and/or the odour of the plant substance and to delay or control its release |
| 04/29/2004 | US20040081690 Film-forming, water soluble polymers that are externally applied to pre-formed tablets |
| 04/29/2004 | US20040081689 Activating a fluid ejector actuator to eject a bioactive fluid onto at least a portion of an interior surface of said enclosing medium |
| 04/29/2004 | US20040081688 Comprising a drug, a lipid matrix and a surfactant characterized in that said drug is a peptide or a protein and lipid matrix has a monoglyceride content which is at least 70% w/w |
| 04/29/2004 | US20040081687 Cholesterol group is linked to the optional linker group via a carbamoyl linkage and then linked to carbohydrate |
| 04/29/2004 | US20040081686 Use of particle vectors in immunomodulation |
| 04/29/2004 | US20040081685 Plurality of patch units connected along one or more borders divisible into respective units allowing dosage to be adjusted |
| 04/29/2004 | US20040081684 Topical delivery of antifungal agents |
| 04/29/2004 | US20040081683 Transdermal delivery system |
| 04/29/2004 | US20040081682 Crystal-free transdermal formulations of the more active (-)-enantiomer of rolipram that are easy to administer |
| 04/29/2004 | US20040081681 Anhydrous formulations for percutaneous absorption |
| 04/29/2004 | US20040081679 Wipe |
| 04/29/2004 | US20040081677 Gel formulations of hydroxypyridone derivatives, which contain solvents and hydrophilic gel-forming agents make possible a high release of the active compound |
| 04/29/2004 | US20040081671 Liquid dosage forms of non-enterically coated acid-labile drugs |
| 04/29/2004 | US20040081670 Method for producing an active ingredient concentrate, and an active ingredient concentrate |
| 04/29/2004 | US20040081668 For the treatment of a hyperpigmented skin condition |
| 04/29/2004 | US20040081645 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/29/2004 | US20040081642 Methods of treating vascular diseases characterized by nitric oxide insufficiency related applications |
| 04/29/2004 | US20040081627 Medicinal aerosol formulations |
| 04/29/2004 | US20040081626 Liquid mixture containing active materials; suspension drops in carrier gas; drug delivery; asthma therapy |
| 04/29/2004 | US20040081625 Nasal formulations for the treatment of allergies |
| 04/29/2004 | US20040081624 Mixture containing high volatility carrier; vaporization; mixing with air |
| 04/29/2004 | US20040079921 Gel; skin penetration enhancers; mixture of hydrotrope, amphiphile and solvent |
| 04/29/2004 | US20040079814 Nasal aromatherapy dispenser clip |
| 04/29/2004 | US20040079700 Production of water for injection using reverse osmosis |
| 04/29/2004 | US20040079671 Medicinal product packaging |
| 04/29/2004 | DE202004002700U1 Viertelbare Tablette Viertelbare tablet |
| 04/29/2004 | DE10296849T5 Verfahren zur Einkapselung eines Wirkstoffes A process for encapsulation of an active ingredient |
| 04/29/2004 | DE10248619A1 Verfahren zur Herstellung pulverförmiger Wirkstoff-Formulierungen mit kompressiblen Fluiden Process for the preparation of powdered active ingredient formulations with compressible fluids |
| 04/29/2004 | DE10248309A1 Delayed release analgesic formulations, comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol in hydrophilic or hydrophobic polymer matrix |
| 04/29/2004 | DE10247399A1 Pharmazeutische Zubereitungen, Verwendung dieser Zubereitung und Verfahren zur Erhöhung der Bioverfügbarkeit von peroral zu applizierenden Arzneistoffen Pharmaceutical preparations, use of this preparation, and methods of increasing the bioavailability of drugs to be administered perorally |
| 04/29/2004 | CA2771725A1 Solid preparation comprising a non-toxic base and a proton pump inhibitor |
| 04/29/2004 | CA2737851A1 Controlled release preparation |
| 04/29/2004 | CA2502502A1 Process for the manufacture of powders of inhalable medicaments |
| 04/29/2004 | CA2502284A1 Bisphosphonates for the treatment of antheroscleorosis and devices comprising them |
| 04/29/2004 | CA2502218A1 Composition with stabilized redox properties and method of stabilization of redox properties |
| 04/29/2004 | CA2502084A1 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 04/29/2004 | CA2501298A1 Method of modifying the release profile of sustained release compositions |
| 04/29/2004 | CA2501201A1 Gastric acid secretion inhibiting composition |
| 04/29/2004 | CA2500987A1 Dosage form of sodium ibuprofen |
| 04/29/2004 | CA2497262A1 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 04/28/2004 | EP1413624A1 Tablet coating |
| 04/28/2004 | EP1413434A1 Pharmaceutical dosage form and method of making |
| 04/28/2004 | EP1413315A1 Sustained-release medicines |
| 04/28/2004 | EP1413312A2 Therapeutic human albumin having a low aluminium binding activity |
| 04/28/2004 | EP1413311A1 Compositions for nasal administration of insulin |
| 04/28/2004 | EP1413310A1 Sustained-release compositions for injection and process for producing the same |
| 04/28/2004 | EP1413298A1 Macrocapsules |
| 04/28/2004 | EP1413297A1 Cyclosporin-containing soft capsule preparations |
| 04/28/2004 | EP1413296A1 Method of fabricating a banded prolonged release active agent dosage form |
| 04/28/2004 | EP1413295A1 Sustained release composition for oral administration of drugs |
| 04/28/2004 | EP1413294A1 COMPOSITIONS CONTAINING SUSTAINED−RELEASE FINE GRAINS FOR TABLETS QUICKLY DISINTEGRABLE IN THE ORAL CAVITY AND PROCESS FOR PRODUCING THE SAME |
| 04/28/2004 | EP1413293A1 Ointment for combatting fungi |
| 04/28/2004 | EP1413292A1 Bioadhesive pharmaceutical compositions based on non-steroidal anti-inflammatory drugs |
| 04/28/2004 | EP1413174A1 Mounting arrangement for auxiliary burner or lance |
| 04/28/2004 | EP1412490A1 Mediating the effects of alcohol consumption by orally administering active dry yeast |
| 04/28/2004 | EP1412462A1 Lanolin substitute, production method thereof and applications of same |
| 04/28/2004 | EP1412424A1 Improvements in or relating to modified cellulose films |
| 04/28/2004 | EP1412377A1 Production of high molecular mass lectins |
| 04/28/2004 | EP1412366A1 Compounds for use as surfactants |
| 04/28/2004 | EP1412068A2 Emulsifier mixture |
| 04/28/2004 | EP1411988A1 Mixed complexes for masking the taste of bitter active substances |
| 04/28/2004 | EP1411986A1 Composition for epigallocatechin gallate |
| 04/28/2004 | EP1411985A1 Treatment of parasitic disease |
| 04/28/2004 | EP1411979A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/28/2004 | EP1411966A2 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 04/28/2004 | EP1411955A1 Sucralose formulations to mask unpleasant tastes |
| 04/28/2004 | EP1411937A2 Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole |
| 04/28/2004 | EP1411926A1 Integrin inhibitors for the treatment of eye diseases |
| 04/28/2004 | EP1411923A1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 04/28/2004 | EP1411921A1 Pharmaceutical compositions containing terbinafin and use thereof |
| 04/28/2004 | EP1411913A1 Antimicrobial nanoemulsion compositions and methods |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411908A1 Treatment of nail infections with no |
| 04/28/2004 | EP1411906A1 Tts with peel-off film with reduced resistance to tearing |
| 04/28/2004 | EP1411905A1 Sustained release delivery system |
| 04/28/2004 | EP1411904A1 Sustained release pharmaceutical composition |
| 04/28/2004 | EP1411903A2 Biodegradable polyhydric alcohol esters |
| 04/28/2004 | EP1411902A2 Two part hard shell capsule made of poly (1,4-alpha-d-glucan)and starch |
| 04/28/2004 | EP1411901A1 Gastric retention controlled drug delivery system |
| 04/28/2004 | EP1411900A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 04/28/2004 | EP1411899A2 Taste masking composition |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411897A2 Compositions and methods for intracellular delivery |
| 04/28/2004 | EP1411896A2 Surfactant compounds and uses thereof |